Directory
>
Deb Steiner
Deb Steiner
Resident, Pediatrics | X4 Pharmaceuticals
Massachusetts, Boston, United States
Deb Steiner
Summary
Deb Steiner is a seasoned executive in the pharmaceutical industry with over 25 years of experience specializing in clinical development and management of Phase 2 to 4 clinical trials. Currently serving as the Vice President of Clinical Development at X4 Pharmaceuticals, Deb has a proven track record in successful new drug registrations and extensive experience in regulatory document preparation. She is adept at building and leading collaborative teams and has developed and managed advisory boards throughout her career. Her expertise spans various therapeutic areas, including mental health and chronic pain management. Deb's strong communication skills have enabled her to present effectively to large organizations and engage with external experts. With a solid educational foundation including an MD and an MS in Management & Policy, she combines scientific knowledge with strategic oversight in her roles.
Deb Steiner
Work Experience
Vice President, Global Head of Clinical Development and Safety at
X4 Pharmaceuticals
August 2024 - Present
Deb Steiner
Education
Vassar College, BA, Science, Technology, & Society/Biochemistry, cum laude
January 1983 - January 1987
Stony Brook University, MS, Management & Policy
January 1994 - January 1998
Icahn School of Medicine at Mount Sinai, MD, Medicine
January 1987 - January 1991
Frequently Asked Questions about Deb Steiner
What is Deb Steiner email address?
Deb Steiner's primary email address is ***********@biogen.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Deb Steiner work for?
Deb Steiner is a Resident, Pediatrics at X4 Pharmaceuticals.
Where Deb Steiner graduated from?
Deb Steiner holds a degree in null from Vassar College.
How can I directly contact Deb Steiner?
To contact Deb Steiner directly, you can use the email address ***********@biogen.com. Complete contact information is available upon registration with Muraena.
Who is Deb Steiner?
Deb Steiner is a seasoned executive in the pharmaceutical industry with over 25 years of experience specializing in clinical development and management of Phase 2 to 4 clinical trials. Currently serving as the Vice President of Clinical Development at X4 Pharmaceuticals, Deb has a proven track record in successful new drug registrations and extensive experience in regulatory document preparation. She is adept at building and leading collaborative teams and has developed and managed advisory boards throughout her career. Her expertise spans various therapeutic areas, including mental health and chronic pain management. Deb's strong communication skills have enabled her to present effectively to large organizations and engage with external experts. With a solid educational foundation including an MD and an MS in Management & Policy, she combines scientific knowledge with strategic oversight in her roles.
Deb`s contact details
***********@biogen.com
***********@x4pharma.com
Colleagues
Associate Scientific Director, Senior Research Scientist
Manager, Healthcare Practice
Executive Assistant to the Board